The 2023 Forbes Global 2000 List

Rechercher dans:
Afficher les résultats contenant...

In this site you will be able to consult a comprehensive ranking of the world's largest and most powerful public companies. Compiled annually by Forbes magazine, the Global 2000 list offers valuable insights into the global economic landscape, highlighting the companies that have achieved remarkable success and prominence in their respective industries.

This prestigious list is a culmination of meticulous research and analysis, encompassing various factors such as revenue, profit, assets, and market capitalization. With over 7,000 companies considered for inclusion, the Global 2000 list showcases the top 2000 corporations that have demonstrated exceptional performance and financial strength.

The list also serves as a valuable resource for investors, analysts, and policymakers, offering valuable data for making informed decisions and assessing market trends. Investors can use the rankings to identify potential opportunities for growth and evaluate the financial stability of companies they may be interested in.

Furthermore, the Forbes Global 2000 list acts as a barometer for the overall health of the global economy, providing a macroscopic view of economic progress across different regions. It helps in understanding which countries and industries are thriving, and which ones are facing challenges.

Source: Forbes (2023).

 
RankNom de l’ entreprisePays
21TotalEnergiesFranceVoir plus
21Verizon CommunicationsUnited StatesVoir plus
23WalmartUnited StatesVoir plus
24CitigroupUnited StatesVoir plus
25China MobileHong KongVoir plus
26China Merchants BankChinaVoir plus
27Postal Savings Bank Of China (PSBC)ChinaVoir plus
28BPUnited KingdomVoir plus
29Volkswagen GroupGermanyVoir plus
30Morgan StanleyUnited StatesVoir plus
31Meta PlatformsUnited StatesVoir plus
32SinopecChinaVoir plus
33BNP ParibasFranceVoir plus
33Goldman Sachs GroupUnited StatesVoir plus
35Tencent HoldingsChinaVoir plus
36AmazonUnited StatesVoir plus
37AllianzGermanyVoir plus
38RBCCanadaVoir plus
39PfizerUnited StatesVoir plus
40Johnson & JohnsonUnited StatesVoir plus